Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Thu, 21st Mar 2019 16:11

Friday 22 March 
Sanne GroupFull Year Results
Smiths GroupHalf Year Results
Henry BootFull Year Results
Monday 25 March 
Medica GroupFull Year Results
Hansteen HoldingsFull Year Results
QuixantFull Year Results
EbiquityFull Year Results
BradyFull Year Results
Pennon GroupTrading Statement 
Tuesday 26 March 
FergusonHalf Year Results
Fevertree DrinksFull Year Results
S&UFull Year Results
Alliance PharmaFull Year Results
Gulf MarineFull Year Results
Access InteligenceFull Year Results
Mysale GroupHalf Year Results
AG BarrFull Year Results
XL MediaFull Year Results
Vectura GroupFull Year Results
TClarkeFull Year Results
Moss BrosFull Year Results
United UtilitiesTrading Statement 
LidcoFull Year Results
Wednesday 27 March 
Inspired EnergyFull Year Results
Touchstone ExplorationFull Year Results
Hilton Food GroupFull Year Results
BellwayHalf Year Results 
CloudcallFull Year Results
Accesso Technology GroupFull Year Results
M&C SaatchiFull Year Results
BH MacroFull Year Results
Anglo Pacific GroupFull Year Results
DiplomaTrading Statement 
Churchill ChinaFull Year Results
Imperial BrandsTrading Statement 
Thursday 28 March 
Eddie Stobart LogisticsFull Year Results
Diurnal GroupHalf Year Results
Tritax EuroboxHalf Year Results
Gulf KeystoneFull Year Results
Arbuthnot Banking GroupFull Year Results
iGas EnergyFull Year Results
MITIE GroupTrading Statement 
Regional REITFull Year Results
Sabre Insurance GroupFull Year Results
Secure Trust BankFull Year Results
SSEFinancial outlook statement
VolexTrading Statement 
Arix BioscienceFull Year Results
Biome TechnologiesFull Year Results
International Public PartnershipsFull Year Results
  

More News
11 May 2020 13:07

UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair

UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair

Read more
15 Apr 2020 14:32

UK TRADING UPDATE SUMMARY: Kromek To Make 2,000 Ventilators For UK

UK TRADING UPDATE SUMMARY: Kromek To Make 2,000 Ventilators For UK

Read more
1 Apr 2020 14:47

Diurnal Gets European Marketing Authorisation For Chronocort

Diurnal Gets European Marketing Authorisation For Chronocort

Read more
6 Mar 2020 17:12

UPDATE: Diurnal Placing Raises GBP11 Million For Drug Development

UPDATE: Diurnal Placing Raises GBP11 Million For Drug Development

Read more
6 Mar 2020 12:40

Diurnal Announces GBP7 Million Placing To Fund Drug Development

Diurnal Announces GBP7 Million Placing To Fund Drug Development

Read more
6 Mar 2020 10:07

Diurnal raises at least ?7m through conditional placing

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced a conditional placing with institutional investors on Friday, to raise at least ?7m before expenses, at a price of 32p per new share.

Read more
5 Mar 2020 17:21

Diurnal Group Names Director Sam Williams Interim Chair

Diurnal Group Names Director Sam Williams Interim Chair

Read more
13 Feb 2020 13:07

Diurnal Says US FDA Accepts New Drug Application For Alkindi Sprinkle

Diurnal Says US FDA Accepts New Drug Application For Alkindi Sprinkle

Read more
13 Feb 2020 09:47

Diurnal clears FDA hurdle for 'Alkindi Sprinkle'

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced on Thursday that its new drug application (NDA) for 'Alkindi', or hydrocortisone granules in capsules for opening and to be known in the US as 'Alkindi Sprinkle', has been accepted for review by the US Food and Drug Administration (FDA).

Read more
11 Feb 2020 13:45

Diurnal narrows loss as it progresses drugs to market

(Sharecast News) - Speciality pharmaceutical company Diurnal Group narrowed its first-half loss by 53% to ?4.6m, it announced on Tuesday, which it said reflected improved revenues and a reduction in clinical development expenses for the period.

Read more
11 Feb 2020 09:20

Diurnal Loss Narrows In First Half Amid Improved Sales Of Alkindi

Diurnal Loss Narrows In First Half Amid Improved Sales Of Alkindi

Read more
4 Feb 2020 15:54

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
20 Jan 2020 11:17

Diurnal In Good Health Ahead Of Second Half Amid Alkindi Progress

Diurnal In Good Health Ahead Of Second Half Amid Alkindi Progress

Read more
16 Dec 2019 13:20

Diurnal Submits Market Authorisation Application For Chronocort

Diurnal Submits Market Authorisation Application For Chronocort

Read more
2 Dec 2019 14:40

Diurnal Submits New Drug Application For Aklindi Sprinkle In US

Diurnal Submits New Drug Application For Aklindi Sprinkle In US

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.